Rheumatoid arthritis: a time to capitalise on drug cost reductions - Health Service Journal

Rheumatoid arthritis: a time to capitalise on drug cost reductions  Health Service Journal

Pfizer commissioned this article written by Dr James Galloway (JG). No honorarium was paid to JG but Pfizer funded the article's publication and has final ...